Clinical Trials Logo

Tissue Breakdown clinical trials

View clinical trials related to Tissue Breakdown.

Filter by:
  • None
  • Page 1

NCT ID: NCT06243744 Active, not recruiting - Skin Laxity Clinical Trials

Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery

Start date: November 30, 2023
Phase: N/A
Study type: Interventional

The goal of this prospective, single-arm clinical study is to gather quantifiable data on Renuvion's impact on skin elasticity and hydration, indicators of skin quality and estimate the biological skin age using DNA methylation in males and females between 18 and 75 years of age who plan to receive a lower facelift surgery. The main purpose is to quantify the effect of the Renuvion device on skin elasticity (collagen density, elastin, fibrillin-1), hydration (aquaporin-3, acidic glycosaminoglycans, HA), and DNA methylation to estimate the biological age of the skin. Participants will receive a lower facelift surgery per the Investigator's standard clinical practice and treatment with the Renuvion APR System.

NCT ID: NCT05469867 Active, not recruiting - Glaucoma Eye Clinical Trials

Pivotal Trial for a Synthetic Tissue Substitute for Concealment of Artificial Ocular Implants

EverPatch
Start date: August 16, 2022
Phase: N/A
Study type: Interventional

This clinical trial will assess the clinical safety and performance of the CorNeat EverPatch device used as a tissue substitute for concealment of artificial ocular implants.

NCT ID: NCT04037917 Terminated - Glaucoma Eye Clinical Trials

First-In-Man Study for an Ophthalmic Synthetic Tissue Substitute

Start date: December 11, 2020
Phase: N/A
Study type: Interventional

Study Name: The CorNeat EverPatch - a First-In-Man Clinical Study for demonstrating the Safety of a Synthetic Tissue Substitute for concealment of artificial implants and glaucoma tube shunts Objective: The objective of this clinical trial is to demonstrate the Safety of the Corneat Everpatch for concealment of artificial implants and glaucoma tube shunts The study will consist 10 subjects requiring concealment of a glaucoma shunt or other ophthalmic implant. Eligible subjects who signs an ICF will be enrolled to the study. Subjects will be implanted with the Corneart EverPatch as part of a glaucoma shunt surgery or during a corrective surgery to repair a breached conjunctiva over an implanted device. Subjects will be monitored for a period of 12 months post-op during which follow up visits will occur at 1 week, 1, 2, 3, 6, 9 & 12 months following surgery including clinical examination of the operated eye using slit-lamp biomicroscopy and imaging using OCT or UBM (will be performed only at the 6 & 12 months follow up visits).

NCT ID: NCT00395980 Completed - Tissue Breakdown Clinical Trials

Muscle Pressure in the Flank Position

Start date: October 2006
Phase: N/A
Study type: Interventional

Using healthy volunteers, participants will lay on an operating room table in various positions employed during kidney surgery. Using a pressure sensor mat, we hope to determine which areas of the body are subject to higher pressures. Using padding devices (foam, gel, water mattress)which are currently used in the operating room will be employed and measurements will be taken to determine which padding material and configurations is optimal to reduce the pressure to those body parts at risk for excessive pressure subject during laparoscopic surgery.